Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Humira
Humira
FDA Approval of Amjevita Need Not Worry AbbVie Shareholders
Yahoo/GuruFocus
Thu, 09/29/16 - 08:14 am
FDA
AbbVie
Amgen
biosimilars
Humira
Amjevita
Shire punts late-stage biosimilars of Humira and Enbrel back to Momenta, Coherus
Endpoints
Wed, 09/28/16 - 10:18 am
Shire
biosimilars
Humira
Enbrel
Momenta
How Much Will Consumers Save on New Humira Biosimilar?
24/7 Wall St
Mon, 09/26/16 - 09:48 am
Humira
biosimilars
Amjevita
AbbVie
Amgen
FDA approves Amgen's copy of AbbVie arthritis drug Humira
Yahoo/Reuters
Fri, 09/23/16 - 10:24 pm
FDA
Amgen
Humira
rheumatoid arthritis
AbbVie
biosimilars
Amgen's Biosimilar Approval And Astra's Anti-PD-L1 Data
Seeking Alpha
Sun, 09/18/16 - 09:54 am
Amgen
biosimilars
AstraZeneca
anti-PD-L1
ABP 501
Humira
durvalumab
AbbVie's Battle Royale
TheStreet.com
Wed, 09/14/16 - 09:25 am
AbbVie
patents
adalimumab
Humira
Abbott Labs
AbbVie’s Humira, Pfizer’s Lyrica dominate a year of TV ad spend with almost $500M total
Fierce Pharma
Mon, 09/12/16 - 05:09 pm
Humira
AbbVie
Lyrica
Pfizer
drug ads
television ads
AbbVie Inc Humira: What are the Future Prospects?
Bidness, ETC
Sat, 08/20/16 - 01:55 pm
AbbVie
Humira
AbbVie Inc, Amgen, Inc: Lengthy Legal Battle Over Humira Begins
Bidness, ETC
Mon, 08/8/16 - 10:03 am
AbbVie
Amgen
Humira
biosimilars
AbbVie Sues Amgen to Fend Off Copy of Blockbuster Humira
Yahoo/Bloomberg
Sat, 08/6/16 - 12:53 pm
AbbVie
Amgen
Humira
generics
biosimilars
rheumatoid arthritis
AbbVie: What Will Happen After Humira?
Seeking Alpha
Thu, 08/4/16 - 09:07 pm
AbbVie
Humira
AbbVie Inc: New Drugs May Overcome Humira Loss
Bidness, ETC
Mon, 08/1/16 - 03:56 pm
AbbVie
Humira
Rova-T
Venclexta
Imbruvica
Viekira Pak
How Abbvie's Humira Undercuts The Drug Industry Price Defense
Forbes
Thu, 07/21/16 - 09:03 am
AbbVie
Humira
drug pricing
FDA Panel Resoundingly Backs Amgen's Biosimilar Humira
Investors.com
Tue, 07/12/16 - 07:03 pm
FDA
advisory panels
Amgen
biosimilars
Humira
ABP 501
FDA panel to review Humira, Enbrel biosimilars this week
BioPharma Dive
Tue, 07/12/16 - 09:22 am
FDA
advisory panels
Humira
Enbrel
biosimilars
ABP-501
Amgen
AbbVie
GP2015
Novartis
Amgen drug appears 'highly similar' to Humira -FDA staff
Yahoo/Reuters
Fri, 07/8/16 - 10:23 am
Amgen
Humira
FDA
Enbrel
rheumatoid arthritis
ABP 501
biosimilars
AbbVie: Not Its First Rodeo
Seeking Alpha
Fri, 06/3/16 - 09:52 am
AbbVie
Humira
patents
AbbVie Slides as U.S. Agency Questions Humira Patent
Bloomberg
Tue, 05/17/16 - 12:07 pm
AbbVie
Humira
patents
Coherus Biosciences
rheumatoid arthritis
With competition lurking, Eli Lilly's baricitinib must show unparalled efficacy
Medical Marketing and Media
Wed, 05/11/16 - 10:52 am
Eli Lilly
baricitinib
JAK inhibitors
Pfizer
Xeljanz
Enbrel
AbbVie
Humira
JNJ
Remicade
Can Humira Still Dominate In 2022?
Seeking Alpha
Thu, 04/21/16 - 03:28 pm
Humira
Amgen
Bristol-Myers Squibb
Coherus Biosciences
Gilead Sciences
Intercept Pharma
JNJ
Novartis
Pfizer
Pages
« first
‹ previous
…
10
11
12
13
14
15
16
17
18
…
next ›
last »